Cargando…

Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosa

PURPOSE: To investigate the main molecular resistance mechanisms to fluoroquinolones (FQs) in Pseudomonas aeruginosa and also to investigate the effect of time and concentration on mutations in resistance genes. MATERIALS AND METHODS: The clinical isolates of P. aeruginosa which are sensitive to cip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Xinyuan, Zhang, Zhiqi, Li, Xiaoxia, Song, Yan, Kang, Jianbang, Yin, Donghong, Gao, Yating, Shi, Nan, Duan, Jinju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371945/ https://www.ncbi.nlm.nih.gov/pubmed/30804676 http://dx.doi.org/10.2147/IDR.S182272

Ejemplares similares

New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations
por: Malik, Seidu, et al.
Publicado: (2012)

Ciprofloxacin binding to GyrA causes global changes in the proteome of Pseudomonas aeruginosa
por: Jedrey, Hannah, et al.
Publicado: (2018)

Repeated Exposure of Escherichia coli to High Ciprofloxacin Concentrations Selects gyrB Mutants That Show Fluoroquinolone-Specific Hyperpersistence
por: Perault, Aurore, et al.
Publicado: (2022)

Fluoroquinolone Resistance Linked to GyrA, GyrB, and ParC Mutations in Salmonella enterica Typhimurium Isolates in Humans
por: Casin, Isabelle, et al.
Publicado: (2003)

Identification of the likely translational start of Mycobacterium tuberculosis GyrB
por: Karkare, Shantanu, et al.
Publicado: (2013)

The role of Gene Mutations (gyrA, parC) in Resistance to Ciprofloxacin in Clinical Isolates of Pseudomonas Aeruginosa
por: Arabameri, Nasibeh, et al.
Publicado: (2021)

Novel phytochemical–antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR
por: Jayaraman, Premkumar, et al.
Publicado: (2013)

Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii
por: Park, Sunok, et al.
Publicado: (2011)

A novel gyrB gene mutation in fluoroquinolone resistant clinical isolates of Mycobacterium tuberculosis
por: Singh, Pooja, et al.
Publicado: (2014)

Characterization of gyrA and parC mutations in ciprofloxacin-resistant Pseudomonas aeruginosa isolates from Tehran hospitals in Iran
por: Farahi, Rosetta Moshirian, et al.
Publicado: (2018)

Frequency and Geographic Distribution of gyrA and gyrB Mutations Associated with Fluoroquinolone Resistance in Clinical Mycobacterium Tuberculosis Isolates: A Systematic Review
por: Avalos, Elisea, et al.
Publicado: (2015)

A Novel Oligonucleotide Pair for Genotyping Members of the Pseudomonas Genus by Single-Round PCR Amplification of the gyrB Gene
por: Agaras, Betina Cecilia, et al.
Publicado: (2018)

A domain insertion in Escherichia coli GyrB adopts a novel fold that plays a critical role in gyrase function
por: Schoeffler, Allyn J., et al.
Publicado: (2010)

The dimer state of GyrB is an active form: implications for the initial complex assembly and processive strand passage
por: Wu, Jinjun, et al.
Publicado: (2011)

Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta
por: Nathania, Ignes, et al.
Publicado: (2022)

Role of core promoter sequences in the mechanism of swarmer cell-specific silencing of gyrB transcription in Caulobacter crescentus
por: England, Jennifer C, et al.
Publicado: (2005)

Multiplex gyrB PCR Assay for Identification of Acinetobacter baumannii Is Validated by Whole Genome Sequence-Based Assays
por: Albert, M. John, et al.
Publicado: (2022)

Characterization of non-classical quinolone resistance in Salmonella enterica serovar Typhi: Report of a novel mutation in gyrB gene and diagnostic challenges
por: Gupta, Ruchi, et al.
Publicado: (2015)

Discovery of seven novel mutations of gyrB, parC and parE in Salmonella Typhi and Paratyphi strains from Jiangsu Province of China
por: Qian, Huimin, et al.
Publicado: (2020)

Discovery and druggability evaluation of pyrrolamide-type GyrB/ParE inhibitor against drug-resistant bacterial infection
por: Zhao, Xintong, et al.
Publicado: (2023)

Molecular Evolution of the Pseudomonas aeruginosa DNA Gyrase gyrA Gene
por: Sada, Mitsuru, et al.
Publicado: (2022)

Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents
por: Tari, Leslie W., et al.
Publicado: (2013)

The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran
por: Nouri, Roghayeh, et al.
Publicado: (2016)

Phylogenomic Analysis Substantiates the gyrB Gene as a Powerful Molecular Marker to Efficiently Differentiate the Most Closely Related Genera Myxococcus, Corallococcus, and Pyxidicoccus
por: Liu, Yang, et al.
Publicado: (2021)

First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of SPR720, a Novel Oral Bacterial DNA Gyrase (GyrB) Inhibitor for Mycobacterial Infections
por: Talley, Angela K., et al.
Publicado: (2021)

Specific patterns of gyrA mutations determine the resistance difference to ciprofloxacin and levofloxacin in Klebsiella pneumoniae and Escherichia coli
por: Fu, Yingmei, et al.
Publicado: (2013)

Association between mutations in gyrA and parC genes of Acinetobacter baumannii clinical isolates and ciprofloxacin resistance
por: Ardebili, Abdollah, et al.
Publicado: (2015)

A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant Neisseria gonorrhoeae and Other High-Threat Pathogens
por: Park, Steven, et al.
Publicado: (2022)

Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam
por: Nguyen, Kinh Van, et al.
Publicado: (2018)

Antimicrobial resistance and novel mutations detected in the gyrA and parC genes of Pseudomonas aeruginosa strains isolated from companion dogs
por: Park, Youjin, et al.
Publicado: (2020)

Hyperbaric Oxygen Sensitizes Anoxic Pseudomonas aeruginosa Biofilm to Ciprofloxacin
por: Kolpen, Mette, et al.
Publicado: (2017)

Activity of Antimicrobial Peptides and Ciprofloxacin against Pseudomonas aeruginosa Biofilms
por: Yasir, Muhammad, et al.
Publicado: (2020)

Thermal Shock and Ciprofloxacin Act Orthogonally on Pseudomonas aeruginosa Biofilms
por: Aljaafari, Haydar, et al.
Publicado: (2021)

Synergistic Effects of Gentamicin, Cefepime, and Ciprofloxacin on Biofilm of Pseudomonas aeruginosa
por: Usman, Muhammad, et al.
Publicado: (2023)

Genetic Diversity of Bacillus thuringiensis from Different Geo-Ecological Regions of Ukraine by Analyzing the 16S rRNA and gyrB Genes and by AP-PCR and saAFLP
por: Punina, N. V., et al.
Publicado: (2013)

Pharmacodynamic Evaluation of Zoliflodacin Treatment of Neisseria gonorrhoeae Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model
por: Jacobsson, Susanne, et al.
Publicado: (2022)

Multidrug Efflux Systems Play an Important Role in the Invasiveness of Pseudomonas aeruginosa
por: Hirakata, Yoichi, et al.
Publicado: (2002)

Using Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) Complemented with Selected 16S rRNA and gyrB Genes Sequencing to Practically Identify Clinical Important Viridans Group Streptococci (VGS)
por: Zhou, Menglan, et al.
Publicado: (2016)

Mechanisms for Development of Ciprofloxacin Resistance in a Clinical Isolate of Pseudomonas aeruginosa
por: Xu, Congjuan, et al.
Publicado: (2021)

Synergy between Indoloquinolines and Ciprofloxacin: An Antibiofilm Strategy against Pseudomonas aeruginosa
por: Charpentier, Emilie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7ajglapl90030qfidg7usokrt2